ArticlePDF Available

Effects of Endurance Training, Hyaluronic Acid and Stem Cell Treatments on the Quadriceps Muscle Fiber Count: Study on the Knee Osteoarthritis Rats

Authors:

Abstract and Figures

Background: Osteoarthritis can impair muscle structure and function. Numerous methods may be helpful for its treatment, i.e., hyaluronic acid, cell therapy, and physical training. Objectives: The present study investigated the independent and combined effect of these three interventions on the quadriceps muscle fiber count in the rat model of knee osteoarthritis. Methods: Fifty four rats were randomly divided into groups, including; healthy-control, osteoarthritis- control, osteoarthritis-training, osteoarthritis-stem cell, osteoarthritis-hyaluronic acid, osteoarthritis-hyaluronic-stem cell, osteoarthritis-stem cell-training, osteoarthritis-hyaluronic acid-training, and osteoarthritis-stem cell-hyaluronic acid-training. The exercise training program consisted of 30 minutes of running on the treadmill with no slope at a speed of 16 m/min for the first week. Then, the duration progressively reached 50 minutes in the eighth week. Stem cells were extracted from bone marrow and injected into the injured joint. Hyaluronic acid was injected into the injured joint in three separate weeks and once a week. All animals were anesthetized 48 hours after the last training session and injections. The samples were removed and sent to the laboratory. All significant levels were considered as P < 0.05. Results: Osteoarthritis significantly decreased muscle fibers compared to healthy animals. Aerobic training, stem cell therapy, hyaluronic acid, the interaction of training and stem cell, and the interaction of training, stem cell therapy, and hyaluronic acid significantly increased muscle fiber count. Conclusions: Concurrent use of aerobic training, stem cell, and hyaluronic acid treatments had more effect than each intervention alone on enhancing the muscle fiber count in the rat model of knee osteoarthritis.
Uncorrected Proof
Thrita. 2020 June; 9(1):e105820.
Published online 2020 August 11.
doi: 10.5812/thrita.105820.
Research Article
Effects of Endurance Training, Hyaluronic Acid and Stem Cell
Treatments on the Quadriceps Muscle Fiber Count: Study on the Knee
Osteoarthritis Rats
Mahboubeh Tajik 1, Mohammad-Ali Azarbayjani 1, *, Maghsoud Peeri 1and Parvin Farzanegi 2
1Central Tehran Branch, Islamic Azad University, Tehran,Iran
2Sari Branch, Islamic Azad University,Sari, Iran
*Corresponding author: Central Tehran Branch, Islamic Azad University,Tehran, Iran. Email: m_azarbayjani@iauctb.ac.ir
Received 2020 May 27; Accepted 2020 June 11.
Abstract
Background: Osteoarthritis can impair muscle structure and function. Numerous methods may be helpful for its treatment, i.e.,
hyaluronic acid, cell therapy, and physical training.
Objectives: The present study investigated the independent and combined effect of these three interventions on the quadriceps
muscle fiber count in the rat model of knee osteoarthritis.
Methods: Fifty four rats were randomly divided into groups, including; healthy-control, osteoarthritis- control, osteoarthritis-
training, osteoarthritis-stem cell, osteoarthritis-hyaluronic acid, osteoarthritis-hyaluronic-stem cell, osteoarthritis-stem cell-
training, osteoarthritis-hyaluronic acid-training, and osteoarthritis-stem cell-hyaluronic acid-training. The exercise training pro-
gram consisted of 30 minutes of running on the treadmill with no slope at a speed of 16 m/min for the first week. Then, the duration
progressively reached 50 minutes in the eighth week. Stem cells were extracted from bone marrow and injected into the injured
joint. Hyaluronic acid was injected into the injured joint in three separate weeks and once a week. All animals were anesthetized 48
hours after the last training session and injections. The samples were removed and sent to the laboratory. All significant levels were
considered as P < 0.05.
Results: Osteoarthritis significantly decreased muscle fibers compared to healthy animals. Aerobic training, stem cell therapy,
hyaluronic acid, the interaction of training and stem cell, and the interaction of training, stem cell therapy, and hyaluronic acid
significantly increased muscle fiber count.
Conclusions: Concurrent use of aerobic training, stem cell, and hyaluronic acid treatments had more effect than each intervention
alone on enhancing the muscle fiber count in the rat model of knee osteoarthritis.
Keywords: Osteoarthritis, Aerobic Training, Stem Cell, Hyaluronic Acid
1. Background
Osteoporosis, osteoarthritis, and sarcopenia are the
most common musculoskeletal disorders (1). Osteoarthri-
tis is a chronic degenerative joint disease characterized by
pain, articular stiffness, and an incremental decrease in
the articular function, which significantly affects the qual-
ity of life (2). Synovial membrane inflammation, articular
capsule thickening, muscle weakness, and new bone for-
mation are complications of osteoarthritis. Therefore, os-
teoarthritis affects not only the tissues inside the capsule
but also the tissues surrounding the joint, including the
muscle (3). Due to its nature, it is reported that osteoarthri-
tis is closely associated with sarcopenia (4,5).
Muscle damage and weakness in people with os-
teoarthritis are usually associated with muscle fiber atro-
phy (6). It has been reported that in subjects with hip and
knee articular osteoarthritis, the cross-sectional area of the
muscle reduces by 12 to 19% (7).
Various methods are suggested to inhibit the negative
effects of osteoarthritis. One of the most common of these
methods is the use of physical training, which includes re-
sistance, stretching, or aerobic training in water and land.
Both high and low-intensity aerobic training are reported
to be suitable for people with osteoarthritis (8). Since the
main goal of osteoarthritis treatment is to alleviate joint
pain, minimize motor disability, and improve aerobic fit-
ness, therefore, aerobic or resistance training can be rec-
ommended as the main treatment for people with mild to
Copyright © 2020, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License
(http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly
cited.
Uncorrected Proof
Tajik M et al.
moderate osteoarthritis (9).
There is evidence that the use of stem cells can have
therapeutic effects on osteoarthritis (10). In animal mod-
els, stem cell therapy can protect or improve induced os-
teoarthritis (11). Stem cells do not appear to become chon-
drocytes, but rather suppress synovial activation and indi-
rectly reduce cartilage damage (12).
Hyaluronic acid has also recently been used as a very ef-
fective treatment for osteoarthritis pain (13). Cell prolifer-
ation is one of the most important stages of muscle regen-
eration after injury (14). Hyaluronic acid is essential for the
removal of fibroblasts from the extracellular matrix and
mitosis (15).
2. Objectives
The current study aimed to investigate the indepen-
dent and combined effect of aerobic training, stem cells,
and hyaluronic acid treatments on the quadriceps muscle
fiber count in the rat model of knee osteoarthritis.
3. Methods
3.1. Ethical Considerations
The present study was in accordance with the National
Institute of Health Publication, and all the ethical princi-
ples were observed regarding working with laboratory an-
imals. It was also approved by the Animal Care and Main-
tenance Committee of the Islamic Azad University of Sari
Branch (no.: IR.MIAU.RECE.1396.132).
3.2. Animals
Fifty four Wistar male rats, aging 2 to 3 months with
a mean initial weight of 250 to 300 g, were divided into
9 groups (each with six subjects), including healthy-
control, osteoarthritis- control, osteoarthritis-training,
osteoarthritis-stem cell, osteoarthritis-hyaluronic acid,
osteoarthritis-hyaluronic-stem cell, osteoarthritis-stem
cell-training, osteoarthritis-hyaluronic acid-training, and
osteoarthritis-stem cell-hyaluronic acid-training. Rats
were housed in cages (each shelf held three rats) with
dimensions of 42 ×26.5 ×15 and in a room with con-
trolled conditions (i.e. 22 ±2°C, 55 ±5 % humidity, and
a 12:12 light-dark cycle with appropriate ventilation). The
animals were fed a daily pellet of 10 g per 100 g of body
weight made by Karaj Behparvar Co. (according to weekly
weighing) and had access to free water through special
bottles.
3.3. Induction of Knee Osteoarthritis
Osteoarthritis was induced using a surgical procedure
developed by Bendele et al. (16). Rats were anesthetized
by ketamine (30 - 50 mg/kg) and xylazine (3 - 5 mg/kg). Af-
ter correcting the right knee, a 1 cm incision was made to
make the knee joint appear. Then, the knee joint was im-
mediately opened by a lateral dislocation of the patellar
bone and the patellar ligament. A longitudinal incision
was made through the parapatellar medial incision. The
lateral dislocation of the patella and patellar ligament was
performed by forceps and then an incomplete incision was
made in the anterior cruciate ligament without damage to
the articular cartilage and other ligaments. Finally, an ar-
ticular capsule with 6 absorbable sutures and skin with 6
silk sutures were closed. The rats were fed standard food
and water for three weeks (16).
3.4. Hyaluronic Acid Treatment
In the hyaluronic acid receiving groups, hyaluronic
acid was injected into the injured joint in three separate
weeks and once a week. The intra-articular injections of
25 µL of HA (Hyalgan®sodium hyaluronate; FidiaFarma-
ceutici S.p.A., AbanoTerme, Italy) was administered using a
27 gauge, 0.5-inch needle. The dose calculated for rats was
determined with reference to the human, as suggested by
Paget and Barnes (17).
3.5. MSCs Intra-Articular Preparation and Injection
MSCs were extracted from the bone marrow of healthy
Wistar rats (250 - 300 g) after inducing anesthesia with ke-
tamine (30 - 50 mg/kg) and xylazine (3 - 5 mg/kg). Isolated
MSCs were cultured in the DMEM medium with 20% FBS in-
cubated overnight to select adherent cells. Cultures were
changed from flask medium every three days to remove
unadhered cells, and MSCs reached < 90% purity after 3
to 4 times passage and were selected for injection. Rats in
the MSCs group received 1 ×106cells/kg by intra-articular
injection of MSCs. MSCs were injected into the right knee
joint of the rats (18).
3.6. Preparation of Tissue Samples and the Way to Measure the
Number of Muscle Fibers
After performing the study, all animals were anes-
thetized and sacrificed by an intraperitoneal injection of
ketamine (60 mg/kg of body weight) and xylazine (5 mg/kg
of body weight), followed by 12 to 14 hours of fasting and 48
hours after the last training session and injections (to elim-
inate the acute effects of training and supplementation),
a completely similar process was used for all cases. The
cartilage and quadriceps muscle were carefully separated
2 Thrita. 2020; 9(1):e105820.
Uncorrected Proof
Tajik M et al.
and washed with distilled water in 10% formalin (Merck,
Germany). After 48 hours of tissue fixation, tissue sam-
ples underwent paraffin molding for histological prepara-
tion. The specimens were then placed in ascending series
of alcohols from 70% to 100% (Merck, Germany), and then
they were exposed to xylol (Merck, Germany) and paraffin
(Merck, Germany) and molded; then using a microtome
(Leica, USA), a 5-micron incision was provided. Each speci-
men was then stained with hematoxylin and eosin (Merck,
Germany) and imaged by light microscopy (Lambda, USA).
From each sample, 5 different fields were randomly eval-
uated at 400 magnification using Image J software (NIH
USA), and the percentage of osteoarthritis injury and the
number of peripheral muscle nuclei were counted by soft-
ware.
3.7. Training Protocol
One month after surgery, one week was spent for famil-
iarizing and adjusting to the research environment and
the treadmill. For this purpose, animals were planned to
run on the treadmill 3 days a week for 10 minutes at a speed
of 16 m/min with 60% - 70% of Vo2max and 0% slope. No
stimuli were applied to move the animals at this stage. The
training protocol consisted of 30 minutes of running on
the treadmill with no slope at a speed of 16 m/min for the
first week. Then, to observe the principle of overload, the
training duration progressively reached 50 minutes in the
eighth week. Before each training session began and af-
ter it was completed, the animals performed warm-up and
cooling for five minutes at a speed of 8 m/min. The control
group was only on the off treadmill during the training ses-
sion with the same time period.
3.8. Statistical Analyses
Descriptive statistics were used to classify and deter-
mine the distribution parameters. The Shapiro-Wilk test
was used to detect data distribution. To investigate the
changes between the groups, a three-way analysis of vari-
ance (ANOVA) and t-test were used. The results were fol-
lowed with a Bonferroni post hoc test. All significant levels
were considered as P < 0.05 (using the SPSS (version 22))
for determining the difference between variables.
4. Results
4.1. Articular Cartilage Area Repair in Different Experimental
Groups
According to the results of the histology section of the
articular cartilage, the extent of tissue damage in the artic-
ular cartilage in the groups receiving hyaluronic acid alone
or in the bone marrow stem cells was not significantly dif-
ferent from the observed model in articular cartilage. Al-
though new cells were found at this site, they were not able
to lead to complete repair of the damaged area. On the
other hand, the results of the combination therapy section
that was associated with exercise training indicated signif-
icant improvement. Based on the results shown in the tis-
sue images, exercise training along with stem cell therapy
or hyaluronic acid also produced a 50% improvement in
tissue, but the combination of all factors led to a better
chondrocyte orientation (Figure 1).
4.2. Evaluation of the Quadriceps Muscle Fiber Count in Differ-
ent Experimental Groups
Based on the results in this section, the number of mus-
cle fibers with a magnification of 400 and at a cross-section
of 300 µm was significantly reduced in the model group;
besides, according to the results, the quadriceps muscle
fiber count in the combination groups was significantly
higher than the model group or the treatment group alone
(Figures 2-4).
4.3. The Effect of Study Interventions on Quadriceps Muscle
Fiber Count
The results showed that the fiber count significantly
decreased responses to knee osteoarthritis (P = 0.001) (Fig-
ure 3).
Aerobic exercise training significantly increased the
fiber count (F = 3006.846, P = 0.001, µ= 0.987). Stem cell
therapy also increased the fiber count significantly (F =
2492.665, P = 0.001, µ= 0.984). Hyaluronic acid intake sig-
nificantly increased the fiber count (F = 794.089, P = 0.001,
µ= 0.952).
Interaction of aerobic exercise training and stem cell
therapy (F = 39.148, P = 0.001, µ= 0.495) increased the
fiber count. A combination of aerobic exercise training
and stem cell therapy increased the fiber count more com-
pared to each one alone.
Although the number of fibers in the aerobic exer-
cise training and hyaluronic acid combination group was
higher than that of the hyaluronic acid alone group, their
combination (F = 0.734, P = 0.397, µ= 0.018) had no signif-
icant interactive effect on the fiber count. Interaction of
stem cell therapy and hyaluronic acid (F = 0.164, P = 0.397, µ
= 0.004) also had no additive effect on the fiber count. On
the other hand, when the three interventions of the exer-
cise training, stem cell therapy, and hyaluronic acid were
applied concurrently, they had an additive effect on the
number of fibers (F = 174.21, P = 0.001, µ= 0.813) (Figure 4).
Thrita. 2020; 9(1):e105820. 3
Uncorrected Proof
Tajik M et al.
Figure 1. Knee articular cartilage in the injured area after treatment with stem cells, hyaluronic acid, aerobic exercise training, or a combination; magnification of images is
400×, with hematoxylin-eosin staining. EXE, Aerobic exercise training; Hyalon, hyaluronic acid; MSCs, stem cell therapy.
5. Discussion
The findings of this study primarily showed that
quadriceps muscle fiber count was significantly reduced
by the induction of osteoarthritis. There are several possi-
ble mechanisms that may explain this reduction: (1) It is re-
ported that expression of MuRF-1 (as one of the major pro-
teins involved in the activation of the muscular atrophy
pathway) increases under conditions of knee osteoarthri-
tis induction in quadriceps (19); (2) osteoarthritis intensi-
fies the pain, and due to the decreased motion, the me-
chanical pressure required to stimulate protein synthesis
pathways in the muscle decreases (20,21). In this regard, De
Ceuninck et al. (22) noted that in the conditions of hip and
knee articular osteoarthritis, lower limb muscle strength
reduces. These changes in muscle protein content, bring
about atrophy and subsequently cause muscle strength
to similarize to non-training and inactive conditions (23);
(3) another possible mechanism for osteoarthritis-affected
muscle mass decrease is inflammation (24,25). In os-
teoarthritis, serum concentrations of inflammatory mark-
ers increase, which is correlated with decreased muscle
mass, physical function, and muscle strength (26,27).
Aerobic exercise training, stem cell therapy, and
hyaluronic acid treatment may have a positive effect on
the muscle affected by osteoarthritis. Aerobic training may
reduce the process of muscle destruction in osteoarthritis
patients through reducing inflammation, an issue that
needs further researches. There are several possible mech-
anisms regarding the effect of stem cell therapy. There is
evidence that cell therapy can heal damaged muscles (28).
It has been reported that in rats with muscle destruction,
stem cell infusion induced new myofibrils and stimulate
satellite cell activity (29). On the other hand, stem cells
can modulate macrophage activity and thus inhibit in-
flammatory processes that lead to muscle atrophy (30).
Regarding hyaluronic acid, it has been reported that the
use of hyaluronic acid can reduce pain in osteoarthritic
conditions and increase joint function (31). Accordingly,
reducing pain increases the motor ability and subse-
quently increases one’s ability to perform physical activity,
which can reduce muscle atrophy processes and maintain
muscle mass and subsequently, muscle strength.
5.1. Conclusions
The present study showed that the concurrent use of
aerobic exercise training, stem cell, and hyaluronic acid
4 Thrita. 2020; 9(1):e105820.
Uncorrected Proof
Tajik M et al.
Figure 2. Histological cross-sections of quadriceps muscle fiber count in different groups examined. Eachcell nucleus is considered to represent muscle fiber. Cross-sections
were prepared at a magnification of 400×and stained with hematoxylin and eosin. EXE: Aerobic exercise training; Hyalon, Hyaluronic acid; MSCs, stem cell therapy.
*
0
0.02
0.04
0.06
0.08
0.1
0.12
Control- Osteoarthritis Control-Healthy
Count Fiber/300µm
Figure 3. The comparison of quadriceps muscle fiber count in the healthy-control
and rat model of knee osteoarthritis. Data are presented as mean ±SD. The rats
are six in each group. *represents a significant decrease in quadriceps muscle fiber
count compared to the osteoarthritis-control group.
treatments had more effect than each intervention alone
on enhancing the muscle fiber count in the rat model of
knee osteoarthritis. Therefore, it is recommended that in
the induced osteoarthritis model, concurrent use of these
three interventions could be effective in reducing muscle
damage as one of the major complications of osteoarthri-
tis. However, further studies are needed, particularly in the
human model, to better understand the effects of these in-
terventions.
Acknowledgments
The authors thank all the teachers of the Central
Branch, Islamic Azad University, who helped them with the
research.
Footnotes
Authors’ Contribution: Study design and coordina-
tion: MAA. Performing the experiment: MT. Drafting the
manuscript: MAA, PF, MP, and MT. All authors read and ap-
proved the final manuscript.
Conflict of Interests: The authors report no conflicts of
interest.
Thrita. 2020; 9(1):e105820. 5
Uncorrected Proof
Tajik M et al.
0
0.05
0.1
0.15
0.2
0.25
0.3
Training-
Hyaluronic acid-MSCs
Training- MSCs Training-
Hyaluronic acid
MSCs-
Hyaluronic acid
Training MSCs Hyaluronic Acid Control
Count Fiber / 300 µm
Figure 4. The comparison of quadriceps muscle fiber count in the different groups of thepresent study. Data are presented as mean ±SD. The rats are six in each group.
Ethical Approval: The present study was in accordance
with the National Institute of Health. Regarding working
with Laboratory Animals. Also, it was approved by the Ani-
mal Care and Maintenance Committee of the Islamic Azad
University of Sari Branch (no.: IR.MIAU.RECE.1396.132).
Funding/Support: None.
References
1. Lane NE. Epidemiology, etiology, and diagnosis of osteo-
porosis. Am J Obstet Gynecol. 2006;194(2 Suppl):S3–11. doi:
10.1016/j.ajog.2005.08.047. [PubMed: 16448873].
2. Srikanth VK, Fryer JL, Zhai G, Winzenberg TM, Hosmer D, Jones G.
A meta-analysis of sex differences prevalence, incidence and sever-
ity of osteoarthritis. Osteoarthritis Cartilage. 2005;13(9):769–81. doi:
10.1016/j.joca.2005.04.014. [PubMed: 15978850].
3. Shorter E, Sannicandro AJ, Poulet B, Goljanek-Whysall K. Skeletal Mus-
cle Wasting and Its Relationship With Osteoarthritis: a Mini-Review
of Mechanisms and Current Interventions. Curr Rheumatol Rep.
2019;21(8):40. doi: 10.1007/s11926-019-0839-4. [PubMed: 31203463].
[PubMed Central: PMC6571089].
4. Scott D, Blizzard L, Fell J, Jones G. Prospective study of self-reported
pain, radiographic osteoarthritis, sarcopenia progression, and falls
risk in community-dwelling older adults. Arthritis Care Res (Hoboken).
2012;64(1):30–7. doi: 10.1002/acr.20545. [PubMed: 21739619].
5. Levinger I, Levinger P, TrenerryMK, Feller JA, Bartlett JR, Bergman N, et
al. Increased inflammatory cytokine expression in the vastus lateralis
of patients with knee osteoarthritis. Arthritis Rheum. 2011;63(5):1343–8.
doi: 10.1002/art.30287. [PubMed: 21538317].
6. Taniguchi M, Fukumoto Y, Kobayashi M, Kawasaki T, Maegawa
S, Ibuki S, et al. Quantity and Quality of the Lower Extremity
Muscles in Women with Knee Osteoarthritis. Ultrasound Med
Biol. 2015;41(10):2567–74. doi: 10.1016/j.ultrasmedbio.2015.05.014.
[PubMed: 26099784].
7. Ikeda S, Tsumura H, Torisu T. Age-related quadriceps-dominant mus-
cle atrophy and incident radiographic knee osteoarthritis. J Or-
thop Sci. 2005;10(2):121–6. doi: 10.1007/s00776-004-0876-2. [PubMed:
15815857].
8. Brosseau L, MacLeay L, Robinson V, Wells G, Tugwell P. Intensity of
exercise for the treatment of osteoarthritis. Cochrane Database Syst
Rev. 2003;(2). CD004259. doi: 10.1002/14651858.CD004259. [PubMed:
12804510].
9. Tak E, Staats P, Van Hespen A, Hopman-Rock M. The effects of an exer-
cise program for older adults with osteoarthritis of the hip. J Rheuma-
tol. 2005;32(6):1106–13. [PubMed: 15940775].
10. Murphy JM, Fink DJ, Hunziker EB, Barry FP. Stem cell therapy in a
caprine model of osteoarthritis. Arthritis Rheum. 2003;48(12):3464–74.
doi: 10.1002/art.11365. [PubMed: 14673997].
11. Desando G, Cavallo C, Sartoni F, Martini L, Parrilli A, Veronesi F, et al.
Intra-articular delivery of adipose derived stromal cells attenuates
osteoarthritis progression in an experimental rabbit model. Arthri-
tis Res Ther. 2013;15(1):R22. doi: 10.1186/ar4156. [PubMed: 23360790].
[PubMed Central: PMC3672720].
12. van Lent PL, van den Berg WB. Mesenchymal stem cell therapy in
osteoarthritis: advanced tissue repair or intervention with smoul-
dering synovial activation? Arthritis Res Ther. 2013;15(2):112. doi:
10.1186/ar4190. [PubMed: 23521980]. [PubMed Central: PMC3672811].
13. Hashizume M, Koike N, Yoshida H, Suzuki M, Mihara M. High molec-
ular weight hyaluronic acid relieved joint pain and prevented the
progression of cartilage degeneration in a rabbit osteoarthritis
model after onset of arthritis. Mod Rheumatol. 2010;20(5):432–8. doi:
10.1007/s10165-010-0299-1. [PubMed: 20407800].
14. Barnhart BJ, Cox SH, Kraemer PM. Detachment variants of Chinese
hamster cells. Hyaluronic acid as a modulator of cell detachment.
Exp Cell Res. 1979;119(2):327–32. doi: 10.1016/0014-4827(79)90360-4.
[PubMed: 218830].
6 Thrita. 2020; 9(1):e105820.
Uncorrected Proof
Tajik M et al.
15. Brecht M, Mayer U, Schlosser E, Prehm P. Increased hyaluronate syn-
thesis is required for fibroblast detachment and mitosis. Biochem
J. 1986;239(2):445–50. doi: 10.1042/bj2390445. [PubMed: 3101667].
[PubMed Central: PMC1147299].
16. Bendele AM. Animal models of osteoarthritis. J Musculoskelet Neuronal
Interact. 2001;1(4):363–76. [PubMed: 15758487].
17. Paget GE, Barnes JM. CHAPTER 6 - Toxicity Tests. In: Laurence DR,
Bacharach AL, editors. Evaluation of Drug Activities. Academic Press;
1964. p. 135–66. doi: 10.1016/B978-1-4832-2845-7.50012-8.
18. Li M, Luo X, Lv X, Liu V, Zhao G, Zhang X, et al. In vivo human adipose-
derived mesenchymal stem cell tracking after intra-articular deliv-
ery in a rat osteoarthritis model. Stem Cell Res Ther. 2016;7(1):160.
doi: 10.1186/s13287-016-0420-2. [PubMed: 27832815]. [PubMed Central:
PMC5103374].
19. Cunha JE, Barbosa GM, Castro P, Luiz BLF, Silva ACA, Russo TL, et
al. Knee osteoarthritis induces atrophy and neuromuscular junc-
tion remodeling in the quadriceps and tibialis anterior muscles of
rats. Sci Rep. 2019;9(1):6366. doi: 10.1038/s41598-019-42546-7. [PubMed:
31019213]. [PubMed Central: PMC6482306].
20. Pisters MF, Veenhof C, van Dijk GM, Dekker J, Carpa Study Group.
Avoidance of activity and limitations in activities in patients with
osteoarthritis of the hip or knee: a 5 year follow-up study on the
mediating role of reduced muscle strength. Osteoarthritis Cartilage.
2014;22(2):171–7. doi: 10.1016/j.joca.2013.12.007. [PubMed: 24333296].
21. Holla JF, van der Leeden M, Knol DL, Peter WF, Roorda LD, Lems WF, et
al. Avoidance of activities in early symptomatic knee osteoarthritis:
results from the CHECK cohort. Ann Behav Med. 2012;44(1):33–42. doi:
10.1007/s12160-012-9353-x. [PubMed: 22411212].
22. De Ceuninck F, Fradin A, Pastoureau P. Bearing arms against os-
teoarthritis and sarcopenia: when cartilage and skeletal mus-
cle find common interest in talking together. Drug Discov To-
day. 2014;19(3):305–11. doi: 10.1016/j.drudis.2013.08.004. [PubMed:
23973339].
23. Silva JMS, Alabarse PVG, TeixeiraVON, Freitas EC, de Oliveira FH, Chakr
R, et al. Muscle wasting in osteoarthritis model induced by anterior
cruciate ligament transection. PLoS One. 2018;13(4). e0196682. doi:
10.1371/journal.pone.0196682. [PubMed: 29709011]. [PubMed Central:
PMC5927423].
24. de Oliveira Nunes Teixeira V, Filippin LI, Viacava PR, de Oliveira
PG, Xavier RM. Muscle wasting in collagen-induced arthritis and
disuse atrophy. Exp Biol Med (Maywood). 2013;238(12):1421–30. doi:
10.1177/1535370213505961. [PubMed: 24186267].
25. Kunz RI, Coradini JG, Silva LI, Bertolini GR, Brancalhao RM, Ribeiro
LF. Effects of immobilization and remobilization on the ankle joint
in Wistar rats. Braz J Med Biol Res. 2014;47(10):842–9. doi: 10.1590/1414-
431x20143795. [PubMed: 25140815]. [PubMed Central: PMC4181219].
26. Penninx BW, Abbas H, Ambrosius W, Nicklas BJ, Davis C, Messier SP, et
al. Inflammatory markers and physical function among older adults
with knee osteoarthritis. J Rheumatol. 2004;31(10):2027–31. [PubMed:
15468370].
27. Sanchez-Ramirez DC, van der Leeden M, van der Esch M, Gerritsen M,
Roorda LD, Verschueren S, et al. Association of serum C-reactive pro-
tein and erythrocyte sedimentation rate with muscle strength in pa-
tients with knee osteoarthritis. Rheumatology (Oxford). 2013;52(4):727–
32. doi: 10.1093/rheumatology/kes366. [PubMed: 23275388].
28. Qazi TH, Duda GN, Ort MJ, Perka C, Geissler S, Winkler T. Cell therapy
to improve regeneration of skeletal muscle injuries. J Cachexia Sar-
copenia Muscle. 2019;10(3):501–16. doi: 10.1002/jcsm.12416. [PubMed:
30843380]. [PubMed Central: PMC6596399].
29. De Bari C, Dell’Accio F, Vandenabeele F, Vermeesch JR, Raymackers
JM, Luyten FP. Skeletal muscle repair by adult human mesenchymal
stem cells from synovial membrane. J Cell Biol. 2003;160(6):909–18.
doi: 10.1083/jcb.200212064. [PubMed: 12629053]. [PubMed Central:
PMC2173757].
30. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K,
et al. Bone marrow stromal cells attenuate sepsis via prostaglandin
E(2)-dependent reprogramming of host macrophages to in-
crease their interleukin-10 production. Nat Med. 2009;15(1):42–9.
doi: 10.1038/nm.1905. [PubMed: 19098906]. [PubMed Central:
PMC2706487].
31. Ishijima M, Nakamura T, Shimizu K, Hayashi K, Kikuchi H, Soen S, et
al. Intra-articular hyaluronic acid injection versus oral non-steroidal
anti-inflammatory drug for the treatment of knee osteoarthritis:
a multi-center, randomized, open-label, non-inferiority trial. Arthri-
tis Res Ther. 2014;16(1):R18. doi: 10.1186/ar4446. [PubMed: 24443804].
[PubMed Central: PMC3979073].
Thrita. 2020; 9(1):e105820. 7
... Hyaluronic acid positively affects muscle proliferation in vitro and animal models (68)(69)(70). Although it has been shown that hyaluronic acid can improve function and pain in certain musculoskeletal and soft tissue injuries, its certain effect and superiority to other types of treatments remain a doubt to date (71). ...
Article
Full-text available
Purpose of Review Osteoarthritis (OA) is a subset of joint disorders resulting in degeneration of synovial joints. This leads to pain, disability and loss of independence. Knee and hip OA are extremely prevalent, and their occurrence increases with ageing. Similarly, loss of muscle mass and function, sarcopenia, occurs during ageing. Recent Findings Little is known about the impact of muscle wasting on OA progression; nevertheless, it has been suggested that muscle wasting directly affects the stability of the joints and loss of mobility leads to gradual degeneration of articular cartilage. The molecular mechanisms underlying muscle wasting in OA are not well understood; however, these are probably related to changes in gene expression, as well as epigenetic modifications. Summary It is becoming clear that skeletal muscle wasting plays an important role in OA development and/or progression. Here, we discuss mechanisms, current interventions, such as exercise, and potentially novel approaches, such as modulation of microRNAs, aiming at ameliorating OA symptoms through maintaining muscle mass and function.
Article
Full-text available
Knee osteoarthritis (KOA) is associated with muscle weakness, but it is unclear which structures are involved in the muscle changes. This study assessed morphological alterations and the expression of genes and proteins linked to muscular atrophy and neuromuscular junctions (NMJs) in KOA, induced by anterior cruciate ligament transection (ACLT) in rats. Two groups of rats were assessed: control (without intervention) and KOA (ACLT surgery in the right knee). After 8 weeks, quadriceps, tibialis anterior (TA) and gastrocnemius muscles were analyzed (area of muscle fibers, NMJ, gene and protein expression). KOA group showed atrophy in quadriceps (15.7%) and TA (33%), with an increase in atrogin-1 and muscle RING-finger protein-1 (MuRF-1). KOA group showed quadriceps NMJ remodeling (reduction area and perimeter) and decrease in NMJ diameter in TA muscle. The expression of nicotinic acetylcholine receptor (nAChR) γ-nAChR increased and that of α-nAChR and muscle specific tyrosine kinase (MuSK) declined in the quadriceps, with a decrease in ε-nAChR in TA. MuRF-1 protein expression increased in quadriceps and TA, with no changes in neural cell adhesion molecule (NCAM). In conclusion, ACLT-induced KOA promotes NMJ remodeling and atrophy in quadriceps and TA muscles, associated with inflammatory signs and changes in muscle gene and protein expression.
Article
Full-text available
Diseases that jeopardize the musculoskeletal system and cause chronic impairment are prevalent throughout the Western world. In Germany alone, ~1.8 million patients suffer from these diseases annually, and medical expenses have been reported to reach 34.2bn Euros. Although musculoskeletal disorders are seldom fatal, they compromise quality of life and diminish functional capacity. For example, musculoskeletal disorders incur an annual loss of over 0.8 million workforce years to the German economy. Among these diseases, traumatic skeletal muscle injuries are especially problematic because they can occur owing to a variety of causes and are very challenging to treat. In contrast to chronic muscle diseases such as dystrophy, sarcopenia, or cachexia, traumatic muscle injuries inflict damage to localized muscle groups. Although minor muscle trauma heals without severe consequences, no reliable clinical strategy exists to prevent excessive fibrosis or fatty degeneration, both of which occur after severe traumatic injury and contribute to muscle degeneration and dysfunction. Of the many proposed strategies, cell‐based approaches have shown the most promising results in numerous pre‐clinical studies and have demonstrated success in the handful of clinical trials performed so far. A number of myogenic and non‐myogenic cell types benefit muscle healing, either by directly participating in new tissue formation or by stimulating the endogenous processes of muscle repair. These cell types operate via distinct modes of action, and they demonstrate varying levels of feasibility for muscle regeneration depending, to an extent, on the muscle injury model used. While in some models the injury naturally resolves over time, other models have been developed to recapitulate the peculiarities of real‐life injuries and therefore mimic the structural and functional impairment observed in humans. Existing limitations of cell therapy approaches include issues related to autologous harvesting, expansion and sorting protocols, optimal dosage, and viability after transplantation. Several clinical trials have been performed to treat skeletal muscle injuries using myogenic progenitor cells or multipotent stromal cells, with promising outcomes. Recent improvements in our understanding of cell behaviour and the mechanistic basis for their modes of action have led to a new paradigm in cell therapies where physical, chemical, and signalling cues presented through biomaterials can instruct cells and enhance their regenerative capacity. Altogether, these studies and experiences provide a positive outlook on future opportunities towards innovative cell‐based solutions for treating traumatic muscle injuries—a so far unmet clinical need.
Article
Full-text available
This study aimed to investigate the molecular pathways involved in muscle wasting in an animal model of osteoarthritis (OA) induced by anterior cruciate ligament transection (ACLT) in rats. Reduction of protein syntheses, increased proteolysis and impaired muscle regeneration are important pathways related to muscle wasting, and myogenin, MyoD, myostatin and MuRF-1 are some of their markers. Female Wistar rats were allocated into two groups: OA (submitted to the ACLT) and SHAM (submitted to surgery without ACLT). Nociception, spontaneous exploratory locomotion and body weight of animals were evaluated weekly. Twelve weeks after the disease induction, animals were euthanized, and the right knee joints were collected. Gastrocnemius muscle of the right hind paw were dissected and weighed. Gastrocnemius was used for evaluation of muscle atrophy and expression of IL-1β, TNF-α, Pax7, myogenin, MyoD, myostatin and MuRF-1. Histopathology of the knee confirmed the development of the disease in animals of OA group. Gastrocnemius of OA animals showed a reduction of about 10% in area and an increased IL-1β expression compared to animals of SHAM group. Expression of myostatin was increased in OA group, while myogenin expression was decreased. TNF-α, Pax7, MuRF-1 and MyoD expression was similar in both OA and SHAM groups. Nociception was significantly elevated in OA animals in the last two weeks of experimental period. Spontaneous exploratory locomotion, body weight and weight of gastrocnemius showed no difference between OA and SHAM groups. Gastrocnemius atrophy in OA induced by ACLT involves elevated expression of IL-1β within the muscle, as well as increased expression of myostatin and decreased expression of myogenin. Therefore, muscle wasting may be linked to impaired muscle regeneration.
Article
Full-text available
Background Human adipose-derived mesenchymal stem cells (haMSCs) have shown efficacy in treating osteoarthritis (OA) both preclinically and clinically via intra-articular (IA) injection. However, understanding the mode of action of the cell therapy has been limited by cell tracking capability and correlation between the pharmacokinetics of the injected cells and the intended pharmacodynamics effect. This study aims to explore methodology and to understand in vivo biodistribution of clinical-grade haMSCs labeled with fluorescent dye and injected into an immunocompetent OA rat model. Methods haMSCs labeled with fluorescent dye were investigated for their proliferation and differentiation capabilities. Labeled cells were used to establish detection threshold of a noninvasive biofluorescent imaging system before the cells (2.5 × 10⁶) were injected into a conventional rat OA model induced by medial meniscectomy for 8 weeks. We attempted to reveal the existence of labeled cells in vivo by imaging and a molecular biomarker approach, and to correlate with the in vivo efficacy and physical presence over a follow-up period up to 10 weeks. Results In vitro proliferation and differentiation of haMSCs were not affected by the labeling of DiD dye. Detection thresholds of the labeled cells in vitro and in vivo were determined to be 10⁴ and 10⁵ cells, respectively. When 2.5 × 10⁶ haMSCs were injected into the joints of a rat OA model, fluorescent signals (or >10⁵ cells) lasted for about 10 weeks in the surgical knee joint at the same time as efficacy was observed. Signals in nonsurgical rats only lasted for 4 weeks. The human MSCs were shown to engraft to the rat joint tissues and were proliferative. Human FOXP2 gene was only detected in the knee joint tissue, suggesting limited biodistribution locally to the joints. Conclusions The current study represents the first attempt to correlate cell therapy efficacy on OA with the physical presence of the injected haMSCs in the OA model, and demonstrates that human adipose-derived mesenchymal stem cells persisted for 10 weeks locally in the rat joint, coinciding with the efficacy observed. It is postulated that persistence and/or proliferation of the haMSCs in the joint is required in order to exert their functions on promoting joint regeneration and/or cartilage protection, further supporting the safety and feasibility of IA injection of MSCs for the treatment of OA patients.
Article
Full-text available
A sprained ankle is a common musculoskeletal sports injury and it is often treated by immobilization of the joint. Despite the beneficial effects of this therapeutic measure, the high prevalence of residual symptoms affects the quality of life, and remobilization of the joint can reverse this situation. The aim of this study was to analyze the effects of immobilization and remobilization on the ankle joint of Wistar rats. Eighteen male rats had their right hindlimb immobilized for 15 days, and were divided into the following groups: G1, immobilized; G2, remobilized freely for 14 days; and G3, remobilized by swimming and jumping in water for 14 days, performed on alternate days, with progression of time and a series of exercises. The contralateral limb was the control. After the experimental period, the ankle joints were processed for microscopic analysis. Histomorphometry did not show any significant differences between the control and immobilized/remobilized groups and members, in terms of number of chondrocytes and thickness of the articular cartilage of the tibia and talus. Morphological analysis of animals from G1 showed significant degenerative lesions in the talus, such as exposure of the subchondral bone, flocculation, and cracks between the anterior and mid-regions of the articular cartilage and the synovial membrane. Remobilization by therapeutic exercise in water led to recovery in the articular cartilage and synovial membrane of the ankle joint when compared with free remobilization, and it was shown to be an effective therapeutic measure in the recovery of the ankle joint.
Article
Full-text available
While many of the commonly used conservative treatments for knee osteoarthritis (OA) have been recognized to be effective, there is still insufficient evidence available. Among the pharmacological treatments for knee OA, oral non-steroidal anti-inflammatory drugs (NSAIDs) act rapidly and are recommended for the management of OA. However, frequent and serious adverse effects of NSAIDs have been recognized. Intra-articular injections of hyaluronic acid (IA-HA) for the treatment of knee OA have been shown to reduce pain and improve joint function. However, there has been no qualified direct comparison study of efficacy and safety between IA-HA and NSAIDs for patients with knee OA. The aim of this study was to clarify the efficacy and safety of early-phase IA-HA in comparison to those of NSAID for patients with knee OA. This multi-center, randomized, open-label, parallel-group, non-inferiority comparison study with an oral NSAID involved a total of 200 patients with knee OA. An independent, computer-generated randomization sequence was used to randomly assign patients in a 1:1 ratio to NSAID 3 times per day for five weeks (n = 100) or IA-HA once a week for five weeks (n = 100). The primary endpoint was the percent change in the patient-oriented outcome measure for knee OA, the Japanese Knee Osteoarthritis Measure (JKOM) score. All patients were questioned regarding any adverse events during treatment. The full analysis set (FAS) was used for analysis. The margin of non-inferiority was 10%. The analyses of primary endpoint included 98 patients in the IA-HA group and 86 patients in the NSAID group. The difference in the percent changes of JKOM score between the two intervention arms (IA-HA; -34.7% (P <0.001), NSAID; -32.2% (P <0.001)) was -2.5% (95% confidence interval (CI): -14.0 to 9.1), indicating IA-HA was not inferior to NSAID. The frequency of both withdrawal and adverse events in the IA-HA group were significantly lower than those in the NSAID group (P = 0.026 and 0.004, respectively). The early efficacy of IA-HA is suggested to be not inferior to that of NSAIDs, and that the safety of early-phase of IA-HA is superior to that of NSAIDs for patients with knee OA.Trial registration: UMIN Clinical Trials Registry (UMIN-CTR), UMIN000001026.
Article
The objective of the study described here was to compare lower extremity muscle quantity and quality between individuals with and those without knee osteoarthritis (OA). Twenty-one women with knee OA (mild, n = 8; severe, n = 13) and 23 healthy patients participated. Ultrasonography was used to measure muscle thickness (MT) and echo intensity (EI) of the rectus femoris, vastus intermedius, vastus lateralis, vastus medialis, biceps femoris, gluteus maximus, gluteus medius, gastrocnemius, soleus and tibialis anterior. MTs of the vastus medialis and vastus intermedius were smaller, and EIs of the vastus medialis, vastus intermedius, gluteus medius and tibialis anterior were larger, in the severe OA group compared than in the healthy group. Compared with the healthy group, the mild OA group had decreased MT and enhanced EI. Changes in quality and quantity occurring with knee OA progression differed among muscles. In the vastus medialis, change was observed from an earlier stage. Copyright © 2015 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.
Article
Variants of the Chinese hamster cell line CHO have been isolated and characterized with respect to attachment and trypsin- or EGTA-mediated detachment kinetics, cell morphologies, and the complex carbohydrates (labeled with [3H]glucosamine) of the cell surface. The variant which was more readily detached from the substratum exhibited a more rounded cell shape and had three times more label as hyaluronic acid on the cell surface than the parental cell. The slowly detaching variant had a morphology similar to the parental cell but only half the radioactivity ascribable to hyaluronic acid. Endogenous levels of cAMP were unaltered in the variants. Exogenous dbcAMP caused the cells to elongate and flatten but did not alter the characteristic detachment kinetics. The role of hyaluronic acid as a modulator of the cell substratum interface is discussed.